Arterial gene transfer of the TGF-β signalling protein Smad3 induces adaptive remodelling following angioplasty

A role for CTGF

Rishi Kundi, Scott T. Hollenbeck, Dai Yamanouchi, Brad C. Herman, Rachel Edlin, Evan J. Ryer, Chunjie Wang, Shirling Tsai, Bo Liu, K. Craig Kent

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Aims Although transforming growth factor-beta (TGF-β) is believed to stimulate intimal hyperplasia after arterial injury, its role in remodelling remains unclear. We investigate whether Smad3, a TGF-β signalling protein, might facilitate its effect on remodelling.Methods and resultsUsing the rat carotid angioplasty model, we assess Smad3 expression following arterial injury. We then test the effect of arterial Smad3 overexpression on the response to injury, and use a conditioned media experimental design to confirm an Smad3-dependent soluble factor that mediates this response. We use small interfering RNA (siRNA) to identify this factor as connective tissue growth factor (CTGF). Finally, we attempt to replicate the effect of medial Smad3 overexpression through adventitial application of recombinant CTGF. Injury induced medial expression of Smad3; overexpression of Smad3 caused neointimal thickening and luminal expansion, suggesting adaptive remodelling. Smad3 overexpression, though exclusively medial, caused adventitial changes: myofibroblast transformation, proliferation, and collagen production, all of which are associated with adaptive remodelling. Supporting the hypothesis that Smad3 initiated remodelling and these adventitial changes via a secreted product of medial smooth muscle cells (SMCs), we found that media conditioned by Smad3-expressing recombinant adenoviral vector (AdSmad3)-infected SMCs stimulated adventitial fibroblast transformation, proliferation, and collagen production in vitro. This effect was attenuated by pre-treatment of SMCs with siRNA specific for CTGF, abundantly produced by AdSmad3-infected SMCs, and significantly up-regulated in Smad3-overexpressing arteries. Moreover, periadventitial administration of CTGF replicated the effect of medial Smad3 overexpression on adaptive remodelling and neointimal hyperplasia. ConclusionMedial gene transfer of Smad3 promotes adaptive remodelling by indirectly influencing the behaviour of adventitial fibroblasts. This arterial cell-cell communication is likely to be mediated by Smad3-dependent production of CTGF.

Original languageEnglish (US)
Pages (from-to)326-335
Number of pages10
JournalCardiovascular Research
Volume84
Issue number2
DOIs
StatePublished - Nov 2009

Fingerprint

Smad3 Protein
Connective Tissue Growth Factor
Adventitia
Angioplasty
Transforming Growth Factor beta
Smooth Muscle Myocytes
Genes
Wounds and Injuries
Conditioned Culture Medium
Small Interfering RNA
Hyperplasia
Collagen
Fibroblasts
Tunica Intima
Myofibroblasts
Cell Communication
Research Design
Arteries

Keywords

  • Adventitia
  • Connective tissue growth factor
  • Remodelling
  • Restenosis
  • Smad3
  • TGF-β

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)
  • Physiology

Cite this

Kundi, R., Hollenbeck, S. T., Yamanouchi, D., Herman, B. C., Edlin, R., Ryer, E. J., ... Kent, K. C. (2009). Arterial gene transfer of the TGF-β signalling protein Smad3 induces adaptive remodelling following angioplasty: A role for CTGF. Cardiovascular Research, 84(2), 326-335. https://doi.org/10.1093/cvr/cvp220

Arterial gene transfer of the TGF-β signalling protein Smad3 induces adaptive remodelling following angioplasty : A role for CTGF. / Kundi, Rishi; Hollenbeck, Scott T.; Yamanouchi, Dai; Herman, Brad C.; Edlin, Rachel; Ryer, Evan J.; Wang, Chunjie; Tsai, Shirling; Liu, Bo; Kent, K. Craig.

In: Cardiovascular Research, Vol. 84, No. 2, 11.2009, p. 326-335.

Research output: Contribution to journalArticle

Kundi, R, Hollenbeck, ST, Yamanouchi, D, Herman, BC, Edlin, R, Ryer, EJ, Wang, C, Tsai, S, Liu, B & Kent, KC 2009, 'Arterial gene transfer of the TGF-β signalling protein Smad3 induces adaptive remodelling following angioplasty: A role for CTGF', Cardiovascular Research, vol. 84, no. 2, pp. 326-335. https://doi.org/10.1093/cvr/cvp220
Kundi, Rishi ; Hollenbeck, Scott T. ; Yamanouchi, Dai ; Herman, Brad C. ; Edlin, Rachel ; Ryer, Evan J. ; Wang, Chunjie ; Tsai, Shirling ; Liu, Bo ; Kent, K. Craig. / Arterial gene transfer of the TGF-β signalling protein Smad3 induces adaptive remodelling following angioplasty : A role for CTGF. In: Cardiovascular Research. 2009 ; Vol. 84, No. 2. pp. 326-335.
@article{7632d11491cc48979e0c41db19121b26,
title = "Arterial gene transfer of the TGF-β signalling protein Smad3 induces adaptive remodelling following angioplasty: A role for CTGF",
abstract = "Aims Although transforming growth factor-beta (TGF-β) is believed to stimulate intimal hyperplasia after arterial injury, its role in remodelling remains unclear. We investigate whether Smad3, a TGF-β signalling protein, might facilitate its effect on remodelling.Methods and resultsUsing the rat carotid angioplasty model, we assess Smad3 expression following arterial injury. We then test the effect of arterial Smad3 overexpression on the response to injury, and use a conditioned media experimental design to confirm an Smad3-dependent soluble factor that mediates this response. We use small interfering RNA (siRNA) to identify this factor as connective tissue growth factor (CTGF). Finally, we attempt to replicate the effect of medial Smad3 overexpression through adventitial application of recombinant CTGF. Injury induced medial expression of Smad3; overexpression of Smad3 caused neointimal thickening and luminal expansion, suggesting adaptive remodelling. Smad3 overexpression, though exclusively medial, caused adventitial changes: myofibroblast transformation, proliferation, and collagen production, all of which are associated with adaptive remodelling. Supporting the hypothesis that Smad3 initiated remodelling and these adventitial changes via a secreted product of medial smooth muscle cells (SMCs), we found that media conditioned by Smad3-expressing recombinant adenoviral vector (AdSmad3)-infected SMCs stimulated adventitial fibroblast transformation, proliferation, and collagen production in vitro. This effect was attenuated by pre-treatment of SMCs with siRNA specific for CTGF, abundantly produced by AdSmad3-infected SMCs, and significantly up-regulated in Smad3-overexpressing arteries. Moreover, periadventitial administration of CTGF replicated the effect of medial Smad3 overexpression on adaptive remodelling and neointimal hyperplasia. ConclusionMedial gene transfer of Smad3 promotes adaptive remodelling by indirectly influencing the behaviour of adventitial fibroblasts. This arterial cell-cell communication is likely to be mediated by Smad3-dependent production of CTGF.",
keywords = "Adventitia, Connective tissue growth factor, Remodelling, Restenosis, Smad3, TGF-β",
author = "Rishi Kundi and Hollenbeck, {Scott T.} and Dai Yamanouchi and Herman, {Brad C.} and Rachel Edlin and Ryer, {Evan J.} and Chunjie Wang and Shirling Tsai and Bo Liu and Kent, {K. Craig}",
year = "2009",
month = "11",
doi = "10.1093/cvr/cvp220",
language = "English (US)",
volume = "84",
pages = "326--335",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Arterial gene transfer of the TGF-β signalling protein Smad3 induces adaptive remodelling following angioplasty

T2 - A role for CTGF

AU - Kundi, Rishi

AU - Hollenbeck, Scott T.

AU - Yamanouchi, Dai

AU - Herman, Brad C.

AU - Edlin, Rachel

AU - Ryer, Evan J.

AU - Wang, Chunjie

AU - Tsai, Shirling

AU - Liu, Bo

AU - Kent, K. Craig

PY - 2009/11

Y1 - 2009/11

N2 - Aims Although transforming growth factor-beta (TGF-β) is believed to stimulate intimal hyperplasia after arterial injury, its role in remodelling remains unclear. We investigate whether Smad3, a TGF-β signalling protein, might facilitate its effect on remodelling.Methods and resultsUsing the rat carotid angioplasty model, we assess Smad3 expression following arterial injury. We then test the effect of arterial Smad3 overexpression on the response to injury, and use a conditioned media experimental design to confirm an Smad3-dependent soluble factor that mediates this response. We use small interfering RNA (siRNA) to identify this factor as connective tissue growth factor (CTGF). Finally, we attempt to replicate the effect of medial Smad3 overexpression through adventitial application of recombinant CTGF. Injury induced medial expression of Smad3; overexpression of Smad3 caused neointimal thickening and luminal expansion, suggesting adaptive remodelling. Smad3 overexpression, though exclusively medial, caused adventitial changes: myofibroblast transformation, proliferation, and collagen production, all of which are associated with adaptive remodelling. Supporting the hypothesis that Smad3 initiated remodelling and these adventitial changes via a secreted product of medial smooth muscle cells (SMCs), we found that media conditioned by Smad3-expressing recombinant adenoviral vector (AdSmad3)-infected SMCs stimulated adventitial fibroblast transformation, proliferation, and collagen production in vitro. This effect was attenuated by pre-treatment of SMCs with siRNA specific for CTGF, abundantly produced by AdSmad3-infected SMCs, and significantly up-regulated in Smad3-overexpressing arteries. Moreover, periadventitial administration of CTGF replicated the effect of medial Smad3 overexpression on adaptive remodelling and neointimal hyperplasia. ConclusionMedial gene transfer of Smad3 promotes adaptive remodelling by indirectly influencing the behaviour of adventitial fibroblasts. This arterial cell-cell communication is likely to be mediated by Smad3-dependent production of CTGF.

AB - Aims Although transforming growth factor-beta (TGF-β) is believed to stimulate intimal hyperplasia after arterial injury, its role in remodelling remains unclear. We investigate whether Smad3, a TGF-β signalling protein, might facilitate its effect on remodelling.Methods and resultsUsing the rat carotid angioplasty model, we assess Smad3 expression following arterial injury. We then test the effect of arterial Smad3 overexpression on the response to injury, and use a conditioned media experimental design to confirm an Smad3-dependent soluble factor that mediates this response. We use small interfering RNA (siRNA) to identify this factor as connective tissue growth factor (CTGF). Finally, we attempt to replicate the effect of medial Smad3 overexpression through adventitial application of recombinant CTGF. Injury induced medial expression of Smad3; overexpression of Smad3 caused neointimal thickening and luminal expansion, suggesting adaptive remodelling. Smad3 overexpression, though exclusively medial, caused adventitial changes: myofibroblast transformation, proliferation, and collagen production, all of which are associated with adaptive remodelling. Supporting the hypothesis that Smad3 initiated remodelling and these adventitial changes via a secreted product of medial smooth muscle cells (SMCs), we found that media conditioned by Smad3-expressing recombinant adenoviral vector (AdSmad3)-infected SMCs stimulated adventitial fibroblast transformation, proliferation, and collagen production in vitro. This effect was attenuated by pre-treatment of SMCs with siRNA specific for CTGF, abundantly produced by AdSmad3-infected SMCs, and significantly up-regulated in Smad3-overexpressing arteries. Moreover, periadventitial administration of CTGF replicated the effect of medial Smad3 overexpression on adaptive remodelling and neointimal hyperplasia. ConclusionMedial gene transfer of Smad3 promotes adaptive remodelling by indirectly influencing the behaviour of adventitial fibroblasts. This arterial cell-cell communication is likely to be mediated by Smad3-dependent production of CTGF.

KW - Adventitia

KW - Connective tissue growth factor

KW - Remodelling

KW - Restenosis

KW - Smad3

KW - TGF-β

UR - http://www.scopus.com/inward/record.url?scp=71549123218&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71549123218&partnerID=8YFLogxK

U2 - 10.1093/cvr/cvp220

DO - 10.1093/cvr/cvp220

M3 - Article

VL - 84

SP - 326

EP - 335

JO - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 2

ER -